Exelixis and Merck Collaborate on Zanzalintinib Trials for Cancer
Exelixis, Inc. (Nasdaq: EXEL) and Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, have announced a clinical development collaboration. The partnership will evaluate the investigational tyrosine kinase…
Bausch + Lomb Gets FDA Approval for enVista® Envy™ Intraocular Lens
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, has announced that the U.S. Food and Drug Administration (FDA) has approved the enVista® Envy™ intraocular lens (IOL),…
GE HealthCare Launches User-Friendly Versana Premier Ultrasound System
GE HealthCare (Nasdaq: GEHC) has introduced the Versana Premier™, the latest addition to its Versana ultrasound family. This system is designed to be reliable, affordable, and user-friendly, offering versatile features…
Most SMA Children on Evrysdi Can Sit, Stand, and Walk Independently: Two-Year Study
Genentech, part of the Roche Group, shared encouraging two-year data from the ongoing RAINBOWFISH study at the 29th World Muscle Society Congress (October 8-12, 2024). This study evaluated the efficacy…
FDA Approves FoundationOne® Liquid CDx for Itovebi™ in Breast Cancer with PIK3CA Mutation
Foundation Medicine, Inc. has announced FDA approval for FoundationOne® Liquid CDx as a companion diagnostic for Itovebi™ (inavolisib) when used with palbociclib (Ibrance®) and fulvestrant. This therapy, developed by Genentech,…
FDA Approves Pfizer’s HYMPAVZI™ for Hemophilia A and B Treatment
Pfizer Inc. (NYSE: PFE) has announced that the U.S. Food and Drug Administration (FDA) has approved HYMPAVZI™ (marstacimab-hncq) for routine prophylaxis. This treatment is designed to prevent or reduce the…
Transverse Medical Welcomes Professor Ian T. Meredith to Board of Directors
Transverse Medical, Inc., known for its POINT-GUARD™ Cerebral Embolic Protection device, is excited to announce the appointment of Ian T. Meredith, MD, to its Board of Directors. With over 35…
Aurinia Showcases Real-World Data on LUPKYNIS® for Lupus Nephritis at ASN Kidney Week 2024
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) announced the acceptance of six abstracts, including five poster presentations, at the American Society of Nephrology (ASN) Kidney Week 2024, happening in San Diego, CA…
VISIE™ Inc. Unveils Continuous Anatomic Auto Tracking for Robotic Knee Surgery
VISIE Inc., formerly Advanced Scanners, has successfully showcased Continuous Anatomic Auto Tracking (CAAT) for robotic-assisted total knee arthroplasty (RA-TKA) at its headquarters in Austin, TX. Continuous Anatomic Auto Tracking (CAAT)…
Reproductive Medicine Associates Marks 25 Years of Excellence in Patient Care
Reproductive Medicine Associates (RMA), a leading provider in reproductive services and a pioneer in IVF research, proudly celebrated its 25th anniversary this month. Over the past quarter-century, RMA has made…
Melt Pharmaceuticals Completes Dosing of Final Patient in Phase 3 Study of MELT-300 for Cataract Surgery Sedation
Melt Pharmaceuticals, Inc., a clinical-stage company focused on innovative procedural sedation solutions, has announced the dosing of the last patient in its pivotal Phase 3 study of MELT-300, a non-IV,…
NanoVibronix Partners with Urology Specialist to Boost UroShield Sales in Germany
NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company known for its UroShield®, PainShield®, and WoundShield® Surface Acoustic Wave (SAW) portable ultrasonic therapeutic devices, has announced a non-binding term sheet for…